Brandon Castor

563 total citations
13 papers, 402 citations indexed

About

Brandon Castor is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brandon Castor has authored 13 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brandon Castor's work include Renal cell carcinoma treatment (3 papers), Ubiquitin and proteasome pathways (3 papers) and Viral-associated cancers and disorders (2 papers). Brandon Castor is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Ubiquitin and proteasome pathways (3 papers) and Viral-associated cancers and disorders (2 papers). Brandon Castor collaborates with scholars based in United States, Singapore and Germany. Brandon Castor's co-authors include Jonathan Said, Ngan Doan, Brian Shuch, Allan J. Pantuck, Arie S. Belldegrun, Susanne M. Henning, David S. Finley, David Elashoff, William J. Aronson and Colette Galet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Brandon Castor

13 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandon Castor United States 10 189 135 111 72 59 13 402
Camille Mallouh United States 14 225 1.2× 112 0.8× 101 0.9× 71 1.0× 41 0.7× 35 542
Wenxiang Shen China 9 240 1.3× 90 0.7× 57 0.5× 106 1.5× 34 0.6× 17 396
Laura del Puerto‐Nevado Spain 14 286 1.5× 128 0.9× 108 1.0× 144 2.0× 68 1.2× 35 569
Hijiri Takeuchi Japan 12 184 1.0× 86 0.6× 52 0.5× 96 1.3× 25 0.4× 31 389
Hao Shi China 14 244 1.3× 137 1.0× 165 1.5× 105 1.5× 30 0.5× 31 488
Christine Heinzle Austria 15 378 2.0× 52 0.4× 107 1.0× 77 1.1× 27 0.5× 37 606
Nadège Rabiau France 11 355 1.9× 50 0.4× 105 0.9× 54 0.8× 153 2.6× 18 508
Daya Shankar Srivastava India 12 438 2.3× 34 0.3× 107 1.0× 47 0.7× 41 0.7× 22 617
A. Hirvonen Finland 14 526 2.8× 95 0.7× 215 1.9× 93 1.3× 90 1.5× 19 783
Tinuccia Dettori Italy 11 85 0.4× 50 0.4× 39 0.4× 78 1.1× 64 1.1× 30 352

Countries citing papers authored by Brandon Castor

Since Specialization
Citations

This map shows the geographic impact of Brandon Castor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Castor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Castor more than expected).

Fields of papers citing papers by Brandon Castor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Castor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Castor. The network helps show where Brandon Castor may publish in the future.

Co-authorship network of co-authors of Brandon Castor

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Castor. A scholar is included among the top collaborators of Brandon Castor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Castor. Brandon Castor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sun, Qiao‐Yang, Ling‐Wen Ding, Wenwen Chien, et al.. (2018). The c‐MYC–BMI1 axis is essential for SETDB1‐mediated breast tumourigenesis. The Journal of Pathology. 246(1). 89–102. 33 indexed citations
2.
Chao, Chun, Lanfang Xu, Michael J. Silverberg, et al.. (2015). Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS. 29(15). 1943–1951. 3 indexed citations
3.
Chao, Chun, Michael J. Silverberg, Lanfang Xu, et al.. (2015). A Comparative Study of Molecular Characteristics of Diffuse Large B-cell Lymphoma from Patients with and without Human Immunodeficiency Virus Infection. Clinical Cancer Research. 21(6). 1429–1437. 17 indexed citations
4.
Faltermeier, Claire, Justin M. Drake, Peter M. Clark, et al.. (2015). Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proceedings of the National Academy of Sciences. 113(2). E172–81. 40 indexed citations
5.
Galet, Colette, Ashley Gray, Jonathan Said, et al.. (2013). Effects of Calorie Restriction and IGF-1 Receptor Blockade on the Progression of 22Rv1 Prostate Cancer Xenografts. International Journal of Molecular Sciences. 14(7). 13782–13795. 28 indexed citations
6.
Shuch, Brian, Gennady Bratslavsky, Joanna H. Shih, et al.. (2012). Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. British Journal of Urology. 109(11). 1600–1606. 70 indexed citations
7.
Henning, Susanne M., Piwen Wang, Jonathan Said, et al.. (2012). Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. The Journal of Nutritional Biochemistry. 23(11). 1537–1542. 50 indexed citations
8.
Konijeti, Ramdev, Satomi Koyama, Ashley Gray, et al.. (2012). Effect of a Low-Fat Diet Combined with IGF-1 Receptor Blockade on 22Rv1 Prostate Cancer Xenografts. Molecular Cancer Therapeutics. 11(7). 1539–1546. 11 indexed citations
9.
Aronson, William J., Naoko Kobayashi, R. James Barnard, et al.. (2011). Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy. Cancer Prevention Research. 4(12). 2062–2071. 61 indexed citations
10.
Shuch, Brian, Gennady Bratslavsky, Joanna H. Shih, et al.. (2011). Impact of pathologic tumor characteristics in patients with sarcomatoid renal cell carcinoma.. Journal of Clinical Oncology. 29(7_suppl). 343–343. 1 indexed citations
11.
Finley, David S., Brian Shuch, Jonathan Said, et al.. (2011). The Chromophobe Tumor Grading System is the Preferred Grading Scheme for Chromophobe Renal Cell Carcinoma. The Journal of Urology. 186(6). 2168–2174. 25 indexed citations
12.
Iwanski, Gabriela B., Ngan Doan, Brandon Castor, et al.. (2010). Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. British Journal of Pharmacology. 160(4). 998–1007. 62 indexed citations
13.
Schrage, Matthew, Quang T. Luong, Brandon Castor, et al.. (2009). The PIM1 Oncogene Accelerates TCL1 Driven Lymphomagenesis in a Double-Transgenic Murine Model.. Blood. 114(22). 2968–2968. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026